We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ML
551
DELISTED
MoneyLion Inc.
ML
$503K 0.06%
+12,102
New +$656K
AMSF icon
552
AMERISAFE
AMSF
$573M
$502K 0.06%
10,381
-12,002
-54% -$571K
BRY
553
DELISTED
Berry Corp
BRY
$500K 0.06%
+97,370
New +$595K
TSLX icon
554
Sixth Street Specialty
TSLX
$1.68B
$500K 0.06%
+24,333
New +$512K
QTRX icon
555
Quanterix
QTRX
$164M
$497K 0.06%
38,377
+4,711
+14% +$62.9K
TPB icon
556
Turning Point Brands
TPB
$1.56B
$497K 0.06%
11,524
+3,912
+51% +$149K
BATRK icon
557
Atlanta Braves Holdings Series B
BATRK
$3.27B
$495K 0.06%
12,434
+1,113
+10% +$46.5K
DOV icon
558
Dover
DOV
$27.4B
$495K 0.06%
+2,580
New +$470K
EHAB
559
DELISTED
Enhabit
EHAB
$491K 0.06%
62,130
+49,059
+375% +$427K
LAD icon
560
Lithia Motors
LAD
$8.17B
$490K 0.06%
+1,543
New +$430K
MYRG icon
561
MYR Group
MYRG
$5.31B
$490K 0.06%
+4,791
New +$544K
AGCO icon
562
AGCO
AGCO
$8.96B
$483K 0.06%
+4,939
New +$460K
CUZ icon
563
Cousins Properties
CUZ
$5.22B
$482K 0.06%
+16,344
New +$440K
WTM icon
564
White Mountains Insurance
WTM
$5.46B
$482K 0.06%
284
+148
+109% +$258K
CC icon
565
Chemours
CC
$2.57B
$481K 0.06%
+23,659
New +$484K
BBIO icon
566
BridgeBio Pharma
BBIO
$16.8B
$480K 0.06%
+18,839
New +$495K
GPOR icon
567
Gulfport Energy Corp
GPOR
$2.76B
$474K 0.06%
+3,135
New +$460K
WS icon
568
Worthington Steel
WS
$1.9B
$473K 0.06%
13,896
-1,976
-12% -$67.9K
ONT
569
Onterris Inc
ONT
$740M
$471K 0.06%
+17,926
New +$580K
SFL icon
570
SFL Corp
SFL
$1.61B
$466K 0.06%
+40,302
New +$482K
CNNE icon
571
Cannae Holdings
CNNE
$665M
$466K 0.06%
24,455
+11,430
+88% +$220K
SNEX icon
572
StoneX
SNEX
$8.99B
$465K 0.06%
19,180
-20,621
-52% -$486K
CPT icon
573
Camden Property Trust
CPT
$11.4B
$464K 0.06%
+3,756
New +$444K
VRNS icon
574
Varonis Systems
VRNS
$5.13B
$463K 0.06%
+8,192
New +$431K
FMC icon
575
FMC
FMC
$1.37B
$463K 0.06%
7,016
+766
+12% +$46.9K
21 22
23
24 25

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.